| Mar'20 | Mar'19 | |||||
|---|---|---|---|---|---|---|
Operating activities | ||||||
Net loss | ||||||
-13,139 | -9,188 | |||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Accretion of discount on marketable securities | ||||||
4 | 0 | |||||
Depreciation and amortization | ||||||
199 | 331 | |||||
Stock-based compensation expense | ||||||
2,088 | 377 | |||||
Gain on foreign currency translation | ||||||
-204 | 0 | |||||
Noncash interest income (loss), net | ||||||
0 | -2 | |||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
5,010 | 0 | |||||
Prepaid expenses and other long-term assets | ||||||
562 | 201 | |||||
Accounts payable and accrued liabilities | ||||||
2,421 | 49 | |||||
Deferred revenue | ||||||
5,065 | 0 | |||||
Deferred rent | ||||||
7 | 0 | |||||
Net cash used in operating activities | ||||||
-8,745 | -8,634 | |||||
Investing activities | ||||||
Purchase of marketable securities | ||||||
46,883 | 0 | |||||
Purchase of property and equipment | ||||||
98 | 419 | |||||
Net cash used in investing activities | ||||||
-46,981 | -419 | |||||
Financing activities | ||||||
Proceeds from public offering, net of issuance costs | ||||||
69,842 | 0 | |||||
Proceeds from the sale of convertible preferred stock, net of issuance costs | ||||||
0 | 6,947 | |||||
Proceeds from issuance of common stock, net of repurchases | ||||||
30 | 66 | |||||
Net cash provided by financing activities | ||||||
69,872 | 7,013 | |||||
Net increase (decrease) in cash and cash equivalents | ||||||
14,146 | -2,040 | |||||